吉利德科学Gilead Sciences (GILD) 2012年年度报告「NASDAQ」.pdf

1、GILEAD SCIENCES ANNUAL REPORT 2012GILEAD SCIENCES ANNUAL REPORT 2012Gilead Sciences is a biopharmaceutical company that discovers,develops and commercializes innovative therapeutics in areas of unmet medical need.The companys mission is to advance the care of patients suffering from life-threatening

2、 diseases worldwide.Headquartered in Foster City,California,Gilead has operations in North America,Europe and Asia Pacific.AmBisome,Cayston,Complera,Emtriva,Eviplera,Gilead,Gilead Sciences,the Gilead logo design,Hepsera,Letairis,Ranexa,Stribild,Truvada,Viread,Vistide and Volibris are registered trad

3、emarks of Gilead Sciences,Inc.or one of its related companies.Atripla is a registered trademark of Bristol-Myers Squibb&Gilead Sciences,LLC.Lexiscan is a registered trademark of Astellas U.S.LLC.Tamiflu is a registered trademark of Hoffmann-La Roche Inc.Macugen is a registered trademark of Eyetech,I

4、nc.Full U.S.prescribing information for Gilead products is available at .WE ARE INSPIRED BY THE OPPORTUNITY TO ADDRESS UNMET MEDICAL NEEDS FOR PATIENTS WITH LIFE-THREATENING DISEASES AROUND THE WORLD.COVER:Katie has been living with HIV since she was an infant.Growing up in Maryland,she faced stigma

5、 at a very young age because of her disease.Despite this experience,she maintains a positive outlook on life,which she credits to her supportive family and friends.Because she knows first-hand the importance of support for people facing serious health challenges,Katie plans to devote her career to h

6、elping those in need.She recently graduated from the University of Central Florida and aims to pursue a masters degree in public health.WELCOME TOGILEAD.3STRIBILDNew Tools for HIV PreventionIn July 2012,Truvada became the first product approved by FDA in combination with safer sex practices to reduc